Conflict of interest/Bibliography: Difference between revisions
Jump to navigation
Jump to search
imported>Gareth Leng (New page: {{subpages}} *''Head to head'' BMJ 333 (2009) Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? [http://www.bmj.com/content/339/bmj.b4949 Yes...) |
imported>Gareth Leng No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
* | *"Head to head" ''BMJ'' 333 (2009) Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? | ||
''Ben Goldacre [http://www.bmj.com/content/339/bmj.b4949 Yes](doi:10.1136/bmj.b4949) argues that the financial interests of drug companies lead to distorted evidence, but Vincent Lawton believes that adequate safeguards exist to keep bias in check [http://www.bmj.com/content/339/bmj.b4953.full No]'' | |||
Latest revision as of 04:23, 20 October 2010
- Please sort and annotate in a user-friendly manner. For formatting, consider using automated reference wikification.
- "Head to head" BMJ 333 (2009) Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs?
Ben Goldacre Yes(doi:10.1136/bmj.b4949) argues that the financial interests of drug companies lead to distorted evidence, but Vincent Lawton believes that adequate safeguards exist to keep bias in check No